STEPTRACKERPHARMACOLOGY | CARDIOVASCULAR | HIGH-YIELD REVIEW

Antiarrhythmics II — Classes III, IV & Others

Potassium-channel blockers lengthen repolarization; calcium-channel blockers slow the AV node. A few unclassified drugs — adenosine, magnesium, digoxin — fill specific gaps.

FOCUS ON
Class III = K⁺ channel blockers → ↑ AP duration, ↑ ERP, ↑ QT. Amiodarone (also class I, II, IV effects): AF, VT/VF; toxicity — pulmonary fibrosis, hypo- or hyperthyroidism (iodine), hepatotoxicity, corneal deposits, optic neuropathy, blue-gray skin, photosensitivity, bradycardia; huge Vd, long t½; monitor PFTs, TFTs, LFTs; inhibits CYP (↑ warfarin, digoxin). Sotalol (also β-blocker), dofetilide, ibutilide: torsades risk; dronedarone: no iodine, avoid in HF. Torsades is rare with amiodarone despite ↑ QT. Class IV (verapamil, diltiazem): ↓ AV conduction (↑ PR) — SVT, rate control; avoid in WPW and HFrEF. Adenosine: A1 → ↑ K⁺ out, ↓ Ca²⁺ in AV node → terminates AV-nodal reentrant SVT; t½ seconds; flushing, chest pain, dyspnea, sense of doom; blocked by theophylline/caffeine, potentiated by dipyridamole. Magnesium: torsades. Digoxin: rate control.
DRUG
ACTION
USES
TOXICITY · MONITOR
Amiodarone
K⁺ block (plus Na⁺, β, Ca²⁺ effects) → ↑ AP duration, ↑ QT
AF (rhythm or rate), VT, VF arrest
Lungs, thyroid, liver, eyes, skin, nerves · PFTs, TFTs, LFTs
Dronedarone
Amiodarone analog without iodine
AF maintenance
Contraindicated in HF (↑ mortality), permanent AF
Sotalol
K⁺ block + nonselective β-block
AF, ventricular arrhythmias
Torsades (dose by renal function), bradycardia
Dofetilide · ibutilide
Pure IKr block
AF/flutter conversion and maintenance
Torsades — start in hospital with QT monitoring
Verapamil · diltiazem
L-type Ca²⁺ block in SA and AV nodes → ↓ phase 0 and 4 there, ↑ PR
SVT, AF/flutter rate control, angina, HTN
Bradycardia, AV block, constipation, HF worsening; ↑ digoxin level
Adenosine
A1 (Gi) in AV node → K⁺ efflux, hyperpolarization
Terminate AVNRT/AVRT; unmask flutter waves
Flushing, chest tightness, bronchospasm, brief asystole
Magnesium sulfate
Stabilizes membrane; blocks Ca²⁺ currents
Torsades de pointes, digoxin toxicity arrhythmias
Hypotension, ↓ reflexes
Digoxin
↑ Vagal tone → slows AV node
AF rate control in HF
Toxicity: atrial tachycardia with block, bidirectional VT
Atropine
M2 block
Symptomatic sinus bradycardia, nodal block
Ineffective in infranodal block → pace
Ivabradine
If block in SA node
Inappropriate sinus tachycardia, HF
Phosphenes
Torsades triggers
Class IA, III, macrolides, fluoroquinolones, antipsychotics, methadone, ondansetron, TCAs
Worse with ↓ K⁺, ↓ Mg²⁺, bradycardia, female sex
Treat: IV Mg²⁺, correct K⁺, overdrive pacing or isoproterenol

Picture it — where each class acts on the action potential

−85 mV01234Na⁺ in → class I slows phase 0Ca²⁺ in (plateau)K⁺ out (phase 3)class III prolongsdashed = class III effect (↑ QT)
Ventricular myocytePhase 0 is the Na⁺ upstroke that class I drugs slow; the plateau is held by Ca²⁺ entry; phase 3 repolarization by K⁺ efflux is lengthened by class III drugs, which shows as a longer QT.
−60 mVphase 0: Ca²⁺ in → class IV slowsphase 4 = If (funny current)dashed: flattened by β-block (II), ivabradineadenosine: ↑ K⁺ out, hyperpolarizes
SA and AV nodal cellNo fast Na⁺ upstroke: phase 0 is carried by Ca²⁺ (slowed by class IV). The spontaneous phase 4 rise (funny current) is flattened by β-blockers and ivabradine; adenosine hyperpolarizes the cell through K⁺ efflux.

Schematic diagrams, not to scale.

Mechanism — adenosine at the AV node

Adenosine → A1 receptor
→
↑ K⁺ efflux, ↓ Ca²⁺ entry
→
Transient AV block
→
Reentry circuit through AV node breaks

Give as a rapid IV push near the heart — red cells and endothelium clear it in seconds.

The four classes

CLASS
TARGET
ECG
I
Na⁺ channel
↑ QRS (IA/IC)
II
β receptor
↑ PR
III
K⁺ channel
↑ QT
IV
Ca²⁺ channel (nodes)
↑ PR

How it's tested

COMMON CONFUSIONAmiodarone causes either hypothyroidism (Wolff-Chaikoff) or hyperthyroidism (Jod-Basedow or thyroiditis) — check TFTs before and during.
THE TRAPIn WPW with AF, AV nodal blockers (adenosine, verapamil, digoxin, β-blockers) push impulses down the accessory pathway → VF. Use procainamide or cardioversion.
YOUR APPROACHRegular narrow-complex tachycardia → vagal maneuver → adenosine. Rate control → β-blocker/CCB. Rhythm control → depends on structural disease.

If you see… think…

Pulmonary fibrosis, thyroid change, blue-gray skin → amiodarone
Sense of impending doom, flushing, brief asystole → adenosine
Adenosine less effective in a coffee drinker → caffeine blocks adenosine receptors
Polymorphic VT with long QT → IV magnesium
Antiarrhythmic causing constipation → verapamil
β-blocker that also prolongs QT → sotalol
Amiodarone analog contraindicated in HF → dronedarone
WPW with AF, hemodynamically stable → procainamide (not nodal blockers)
INR rises after amiodarone started → CYP2C9 inhibition
Class with greatest PR prolongation → II and IV